Showing results (1141-1150 of 1,579) with videos related to
Sort By:
Pageof 158
American Journal of Clinical Dermatology|February 6, 2025
Infections in Patients with Atopic Dermatitis and the Influence of TreatmentMaddalena Napolitano, Maria Esposito, Maria Concetta Fargnoli, et al.American Journal of Clinical Dermatology|February 10, 2024
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional StudyHilliard T Brydges, Ogechukwu C Onuh, Rebecca Friedman, et al.American Journal of Clinical Dermatology|January 22, 2024
The Skin Microbiome and its Significance for DermatologistsCleo Whiting, Sara Abdel Azim, Adam FriedmanAmerican Journal of Clinical Dermatology|March 18, 2024
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, CanadaAnastasiya Muntyanu, Raymond Milan, Mohammed Kaouache, et al.American Journal of Clinical Dermatology|March 18, 2024
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal ResistanceRachel C Hill, Avrom S Caplan, Boni Elewski, et al.American Journal of Clinical Dermatology|September 30, 2024
Comparing Tretinoin to Other Topical Therapies in the Treatment of Skin Photoaging: A Systematic ReviewZoya Siddiqui, Alina Zufall, Marissa Nash, et al.American Journal of Clinical Dermatology|September 11, 2024
Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era?Elisabeth V Goessinger, Philippe Gottfrois, Alina M Mueller, et al.American Journal of Clinical Dermatology|November 14, 2023
Non-invasive Skin Imaging in Cutaneous LymphomasEyal Taleb, Oriol Yélamos, Marco Ardigo, et al.American Journal of Clinical Dermatology|August 25, 2023
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2Gil Yosipovitch, Melinda J Gooderham, Sonja Ständer, et al.American Journal of Clinical Dermatology|June 2, 2023
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic DermatitisDiana Bernardo, Thomas Bieber, Tiago TorresPageof 158